MP20-19\u2003THE NOVEL SP PURPOSE-BUILT SINGLE-SITE DEDICATED PLATFORM: REPORT OF THE INITIAL EXPERIENCE

Abstract

INTRODUCTION AND OBJECTIVES: The Da Vinci SP® robotic surgical platform (Intuitive Surgical, Sunnyvale, CA, USA) has been FDA approved and launched on the market. We aimed to report our initial experience with robotic urological interventions. RESULTS: A total of 15 patients were treated (5 robot-assisted radical prostatectomies, 3 transperitoneal robot-assisted partial nephrectomies, 3 cystectomies with intracorporeal ileal conduit urinary diversion, 3 ureteral reimplantations and 1 pyeloplasty). No intraoperative complications occurred. In 6 cases the surgeries were performed according to a pure single-site approach. The mean operative time was slightly longer than the one reported for the respective multi-arm robotic procedures in the published experiences, which can be easily explained by the expected learning curve. One patient required angioembolization after partial nephrectomy. CONCLUSIONS: Major urological interventions were performed by using the Da Vinci SP® robotic surgical platform. The surgery is feasible, and the platform could sponsor the achievement of a pure single-site approach. On the other hand, a learning curve exists when embarking with this surgery and further investigations are awaited. Source of Funding: none